{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:08:00Z","timestamp":1790485680976,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.maturitas.2017.05.014","type":"journal-article","created":{"date-parts":[[2017,5,21]],"date-time":"2017-05-21T10:16:53Z","timestamp":1495361813000},"page":"37-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Long-term cardiovascular health in adult cancer survivors"],"prefix":"10.1016","volume":"105","author":[{"given":"W.R.","family":"Naaktgeboren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Linschoten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"de Graeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"v Rhenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.W.","family":"Asselbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.E.M.","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Teske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2017.05.014_bib0005","first-page":"271","article-title":"Cancer treatment and survivorship statistics 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/1055-9965.EPI-12-1356","article-title":"Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care","volume":"22","author":"de Moor","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0015","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0020","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","article-title":"Late cardiotoxicity after treatment for Hodgkin lymphoma","volume":"109","author":"Aleman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0025","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/asheducation-2016.1.323","article-title":"Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment","volume":"2016","author":"van Leeuwen","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Progr."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0360-3016(00)00647-7","article-title":"The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin\u2019s disease: University of Minnesota experience","volume":"48","author":"Lee","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"April (2)","key":"10.1016\/j.maturitas.2017.05.014_bib0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11764-016-0584-x","article-title":"Cardiovascular disease and physical activity in adult cancer survivors: a nested, retrospective study from the Atlantic PATH cohort","volume":"11","author":"Keats","year":"2017","journal-title":"J. Cancer Surviv."},{"issue":"February (2)","key":"10.1016\/j.maturitas.2017.05.014_bib0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/annonc\/mdw604","article-title":"Causes of death among cancer patients","volume":"28","author":"Zaorsky","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0045","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study","volume":"34","author":"Armenian","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0050","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamacardio.2016.3841","article-title":"A population-based study of cardiovascular mortality following early-stage breast cancer","volume":"2","author":"Abdel-Qadir","year":"2017","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0060","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/heartjnl-2015-307848","article-title":"Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality","volume":"101","author":"Pavo","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0065","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0070","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrcardio.2015.65","article-title":"Cardiotoxicity of anticancer treatments","volume":"12","author":"Ewer","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0075","doi-asserted-by":"crossref","first-page":"e70479","DOI":"10.1371\/journal.pone.0070479","article-title":"Pharmacological induction of transforming growth factor-beta1 in rat models enhances radiation injury in the intestine and the heart","volume":"8","author":"Boerma","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00005792-196705000-00003","article-title":"Heart disease following radiation","volume":"46","author":"Cohn","year":"1967","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0085","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2013.01.090","article-title":"Cardiac complications of thoracic irradiation","volume":"61","author":"Jaworski","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0090","first-page":"519","article-title":"Radiation heart disease. Analysis of 16 young (aged 15\u201333 years) necropsy patients who received over 3,500 rads to the heart","volume":"70","author":"3rd Brosius","year":"1981","journal-title":"Am. J. Med."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.1060191","article-title":"Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice","volume":"293","author":"Paris","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0100","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.echo.2013.07.005","article-title":"Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"26","author":"Lancellotti","year":"2013","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0105","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/eurheartj\/ehm311","article-title":"Radiotherapy effects on systolic myocardial function detected by strain rate imaging in a left-breast cancer patient","volume":"28","author":"Jurcut","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2217\/FCA.15.44","article-title":"Cardiac toxicity in the radiation treatment of esophageal cancer: an emerging concern","volume":"11","author":"Beukema","year":"2015","journal-title":"Future Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0115","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005051","article-title":"Radiation-induced heart disease in lung cancer radiotherapy: a dosimetric update","volume":"95","author":"Ming","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0120","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.amjcard.2016.08.050","article-title":"Meta-analysis of association between mediastinal radiotherapy and long-term heart failure","volume":"118","author":"Nolan","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0125","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0130","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","article-title":"Factors affecting late mortality from heart disease after treatment of Hodgkin\u2019s disease","volume":"270","author":"Hancock","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0135","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0360-3016(97)00467-7","article-title":"Cardiac function perfusion, and morbidity in irradiated long-term survivors of Hodgkin\u2019s disease","volume":"39","author":"Constine","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0140","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0145","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/0002-9149(87)90345-6","article-title":"Clinical and angiographic features of coronary artery disease after chest irradiation","volume":"60","author":"McEniery","year":"1987","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0150","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1200\/JCO.2011.34.5900","article-title":"Distribution of coronary artery stenosis after radiation for breast cancer","volume":"30","author":"Nilsson","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ctrv.2010.12.004","article-title":"Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease","volume":"37","author":"van Leeuwen-Segarceanu","year":"2011","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0160","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bjc.6605191","article-title":"Valvular dysfunction and left ventricular changes in Hodgkin\u2019s lymphoma survivors. A longitudinal study","volume":"101","author":"Wethal","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0165","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/hrt.75.6.591","article-title":"Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin\u2019s disease: an echocardiographic study","volume":"75","author":"Lund","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0170","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1001\/jama.290.21.2831","article-title":"Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy","volume":"290","author":"Hull","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0175","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv008","article-title":"Risk of valvular heart disease after treatment for Hodgkin lymphoma","volume":"107","author":"Cutter","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0180","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jcmg.2015.06.028","article-title":"Valvular dysfunction in lymphoma survivors treated with autologous stem cell transplantation: a national cross-sectional study","volume":"9","author":"Murbraech","year":"2016","journal-title":"JACC. Cardiovasc. Imaging."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0185","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4330\/wjc.v8.i9.504","article-title":"Novel concepts in radiation-induced cardiovascular disease","volume":"8","author":"Cuomo","year":"2016","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0190","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0002-9149(03)00546-0","article-title":"Echocardiographic features of radiation-associated valvular disease","volume":"92","author":"Hering","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.acvd.2012.11.004","article-title":"Anatomical features of rheumatic and non-rheumatic mitral stenosis: potential additional value of three-dimensional echocardiography","volume":"106","author":"Krapf","year":"2013","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0200","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-94-3-338","article-title":"The late appearance of chronic pericardial disease in patients treated by radiotherapy for Hodgkin\u2019s disease","volume":"94","author":"Applefeld","year":"1981","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0205","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/eurheartj\/eht114","article-title":"Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease","volume":"35","author":"Groarke","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0002-9149(92)91393-I","article-title":"Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults","volume":"70","author":"Larsen","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0215","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/1097-0142(19860301)57:5<929::AID-CNCR2820570509>3.0.CO;2-6","article-title":"Incidence of heart disease and functional significance of changes in the electrocardiogram 10 years after radiotherapy for breast cancer","volume":"57","author":"Strender","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0220","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.radonc.2016.08.024","article-title":"Risk of pacemaker or implantable cardioverter defibrillator after radiotherapy for early-stage breast cancer in Denmark, 1982\u20132005","volume":"122","author":"Rehammar","year":"2017","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0225","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/cncr.23378","article-title":"Subclinical late cardiac toxicity in childhood cancer survivors: impact on self-reported health","volume":"112","author":"Cox","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0230","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1200\/JCO.2007.11.0106","article-title":"Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility","volume":"25","author":"Telli","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0235","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.amjcard.2013.08.026","article-title":"Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity","volume":"112","author":"Lotrionte","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0240","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1751-7133.2011.00278.x","article-title":"Subclinical anthracycline cardiotoxicity in patients with acute promyelocytic leukemia in long-term remission after the AIDA protocol","volume":"18","author":"Pellicori","year":"2012","journal-title":"Congest. Heart Fail."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0245","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1470-2045(12)70525-9","article-title":"Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial","volume":"14","author":"Mackey","year":"2013","journal-title":"Lancet. Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0250","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1200\/JCO.2011.40.0010","article-title":"Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal gr","volume":"30","author":"Romond","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11739-015-1362-x","article-title":"Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer","volume":"11","author":"Mantarro","year":"2016","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0260","doi-asserted-by":"crossref","first-page":"e000073","DOI":"10.1136\/esmoopen-2016-000073","article-title":"Twenty years of anti-HER2 therapy-associated cardiotoxicity","volume":"1","author":"Ponde","year":"2016","journal-title":"ESMO Open"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0265","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ctrv.2016.12.002","article-title":"Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: a systematic review and meta-analysis","volume":"53","author":"Abdel-Qadir","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0270","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/1097-0142(197602)37:2+<1070::AID-CNCR2820370814>3.0.CO;2-6","article-title":"The cardiotoxicity of adriamycin and daunomycin in children","volume":"37","author":"Gilladoga","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0275","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.1991.03470120074036","article-title":"Cardiac toxicity 4\u201320 years after completing anthracycline therapy","volume":"266","author":"Steinherz","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0280","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","article-title":"Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities","volume":"64","author":"Vejpongsa","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0285","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0290","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0295","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0305","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0310","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0315","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJMra1100265","article-title":"Cardiovascular toxic effects of targeted cancer therapies","volume":"375","author":"Moslehi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0320","doi-asserted-by":"crossref","first-page":"e5195","DOI":"10.1097\/MD.0000000000005195","article-title":"Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: a meta-analysis","volume":"95","author":"Jawa","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0325","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1200\/JCO.2016.67.4846","article-title":"Obesity as a risk factor for anthracyclines and trastuzumab cardiotoxicity in breast cancer: a systematic review and meta-analysis","volume":"34","author":"Guenancia","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0330","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","article-title":"The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with a","volume":"57","author":"Fallah-Rad","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0335","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2016.08.022","article-title":"The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer","volume":"68","author":"Abdel-Qadir","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0340","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jamaoncol.2016.0429","article-title":"Cardiovascular disease after aromatase inhibitor use","volume":"2","author":"Haque","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0345","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/jamaoncol.2015.4917","article-title":"Comparison of gonadotropin-releasing hormone agonists and orchiectomy: effects of androgen-deprivation therapy","volume":"2","author":"Sun","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0350","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1200\/JCO.2014.59.1792","article-title":"Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancer","volume":"33","author":"O\u2019Farrell","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0355","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.eururo.2015.08.027","article-title":"Cardiovascular mortality following short-term androgen deprivation in clinically localized prostate cancer: an analysis of RTOG 94-08","volume":"69","author":"Voog","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0360","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/eci.12431","article-title":"Pharmacologic androgen deprivation and cardiovascular disease risk factors: a systematic review","volume":"45","author":"Romo","year":"2015","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0365","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome-a new world-wide definition. a consensus statement from the international diabetes federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet. Med."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0370","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1470-2045(09)70287-6","article-title":"The metabolic syndrome in cancer survivors","volume":"11","author":"de Haas","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0375","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/ijc.28334","article-title":"Arterial hypertension and cancer","volume":"134","author":"Milan","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.maturitas.2017.05.014_bib0380","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2010.29.9362","article-title":"Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study","volume":"28","author":"Haugnes","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2017.05.014_bib0385","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40959-016-0014-2","article-title":"Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic","volume":"2","author":"Barros-Gomes","year":"2016","journal-title":"Cardio-Oncology"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512217304772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512217304772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:11:49Z","timestamp":1759914709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512217304772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":77,"alternative-id":["S0378512217304772"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2017.05.014","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term cardiovascular health in adult cancer survivors","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2017.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}